2026 24th China Pharmaceutical Raw Materials Exhibition

In 2024, China's pharmaceutical exports are characterized by scale growth, structural optimization, and market diversification. Against the backdrop of high-quality internationalization of the pharmaceutical industry, innovative drugs and biopharmaceuticals have become new driving forces for export growth, with increasingly diverse overseas models emerging. With the rise of emerging markets, the potential for China's pharmaceutical product exports will be further explored, and pharmaceutical companies will encounter greater market opportunities. As the 'business card' representing China's pharmaceutical industry to the world, the China Pharmaceutical Raw Materials Exhibition (CPHI China) and the China International Pharmaceutical Machinery, Packaging Equipment and Materials Exhibition (PMEC China) will work together to maintain their leading position in the industry based on global perspective, professionalism, and differentiated advantages. The two major exhibitions will focus precisely on the growth hotspots of the pharmaceutical industry, keenly capture global market trends, promote cross-regional collaborative development, and strive to build a high-quality platform for trade, investment, communication, and cooperation. From June 16-18, 2026, CPHI & PMEC China will ignite once again in Shanghai. The exhibition will gather the pioneering forces of the global pharmaceutical industry, deeply link international markets and quality resources, accelerate the cultivation and formation of new productive capabilities, and lead China's pharmaceutical industry to continue rising towards the high end of the value chain. Products on display will include a variety of pharmaceuticals such as APIs, vitamins, hormones, analgesics, anesthetics, and antibiotics. Additionally, the exhibition will showcase the latest technologies in biopharmaceuticals, as well as industry trends related to natural extracts and bioproducts, to facilitate technical exchanges and cooperation among enterprises.